High-resolution real-time imaging reveals early developmental processes in quail embryos

Pfiz­er is set to stop con­struc­tion of a man­u­fac­tur­ing fa­cil­i­ty start­ed by Seagen in Wash­ing­ton state, with af­fect­ed em­ploy­ees pos­si­bly mov­ing to oth­er fa­cil­i­ties, a

Abpro, an an­ti­body mak­er work­ing on T cell en­gagers that tar­get HER2+ can­cer types, is go­ing pub­lic through merg­ing with a SPAC com­pa­ny dubbed At­lantic

Notably, the number of microbiome-related patent applications in the pharmaceutical industry was 102 in Q2 2023, versus 125 in the prior quarter. The top five